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Abstract.  Platelet aggregation  requires the binding  of 
fibrinogen  to its receptor,  a  heterodimer  consisting  of 
the plasma-membrane  glycoproteins (GP) lib and Ilia. 
Although  the GPIIb-IIIa complex is present on the 
surface of unstimulated  platelets,  it binds  fibrinogen 
only after platelet activation.  We have used an 
immunogold-surface  replica technique  to study the dis- 
tribution  of GPIib-IIIa  and bound fibrinogen over 
broad areas  of surface membranes  in unstimulated,  as 
well as thrombin-activated  and ADP-activated  human 
platelets.  We found that the immunogold-labeled 
GPIib-IIIa  was monodispersed  over the surface of un- 
stimulated platelets,  although  the cell surface lacked 
immunoreactive  fibrinogen.  On thrombin-stimulated 
platelets,  ~-65 %  of the GPIIb-IIIa molecules were in 
clusters within  the plane of the membrane.  Fibrinogen, 
which had been released  from the  a-granules  of these 
cells,  bound to GPIIb-IIIa on the cell surface and was 
similarly  clustered.  To determine  whether the recep- 
tors clustered before ligand  binding,  or as a conse- 
quence thereof,  we studied the surface distribution  of 
GPIIb-IIIa after stimulation  with ADP,  which causes 
activation  of the fibrinogen  receptor function of GPIIb- 
Ilia  without inducing  the release  of fibrinogen.  In the 
absence of added fibrinogen,  the unoccupied,  yet bind- 
ing-competent  receptors on ADP-stimulated  platelets 
were monodispersed.  The addition  of fibrinogen 
caused the GPIIb-IIIa molecules to cluster on the cell 
surface.  Clustering  was also induced by the addition of 
the GPIIb-IIIa-binding  domains of fibrinogen,  namely 
the tetrapeptide  Arg-Gly-Asp-Ser on the a-chain  or the 
7-chain decapeptide 7402-411.  These results show that 
receptor occupancy causes clustering  of GPIIb-IIIa in 
activated platelets. 
p 
LATELET aggregation requires the binding of fibrino- 
gen  to  its  membrane  receptor,  glycoproteins  (GP) 1 
Ub and IIIa (reviewed in reference 16). Fibronectin, 
von Willebrand factor, and vitronectin also bind to GPIIb- 
IIIa (12, 39, 45). The interaction of these ligands with the sur- 
face of platelets may potentiate aggregation and possibly the 
adherence  of platelets  to exposed vascular  subendothelial 
surfaces (20, 55). GPIIb-IIIa is a complex consisting of two 
large, nonidentical glycoproteins, GPIIb and GPIIIa, which 
interact by a noncovalent, Ca2+-dependent mechanism (23). 
Although  the  intact  heterodimer  is present  in  the plasma 
membrane of unstimulated platelets (ll, 29, 38), the receptor 
does not bind  fibrinogen or other ligands  unless the cells 
have been activated by an agonist such as ADP or thrombin 
(3,  12, 39). This suggests that cell activation induces a con- 
1. Abbreviations  used in this paper:  GP, glycoprotein; RGDS, Arg-Gly-Asp- 
Ser;  RGES,  Arg-Giy-Glu-Ser; "/402-411,  Leu-Gly-Gly-Ala-Lys-Gln-Ala- 
Gly-Asp-Val. 
A portion of this work was published in abstract form (1985. J.  Cell Biol. 
101:670a). 
formational  change in GPl/b-IIIa or "microenvironmental" 
changes in the plasma membrane that allow freer access of 
ligands to the receptor (9,  36,  51). 
Previous  investigators,  using  immunocytochemical  and 
electron-microscopic techniques, have found that GPIIb-IIIa 
and fibrinogen cluster in the membrane of activated platelets. 
Polley et al. (43) reported co-clustering of GPIIb and GPIIIa 
in the membranes isolated from thrombin-stimulated  plate- 
lets. Observations of thin sections of platelets, which permit 
visualization of only small amounts of membrane, have also 
revealed clustering of GPIIb-IIIa or fibrinogen (1, 21). These 
studies, however, are difficult to relate to the mechanism of 
receptor expression during platelet activation, because it was 
not determined whether clustering was an effect of platelet 
activation per se, the binding of fibrinogen to GPIIb-IIIa, or, 
in the study on isolated membranes (43), the membrane iso- 
lation procedure. 
In the present study, we used a combined postfixation im- 
munogold-surface replica technique to examine the distribu- 
tion of the fibrinogen receptor and its bound ligand on the 
surface of unstimulated platelets and platelets activated with 
thrombin or ADP. This procedure allows the visualization of 
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We found that clustering of GPIIb-IIIa in the membrane of 
activated platelets occurred only after fibrinogen or one of 
its  GPIIb-IIIa binding-specific peptides  had  occupied the 
receptor. 
Materials and Methods 
Collection of Specimens 
Platelets were isolated from the blood of aspirin-free human volunteers by 
the techniques described by Stenberg et at.  (52),  with one modification. 
Because GPIIb-llIa is a  calcium-dependent complex (11, 23), EDTA was 
omitted from all buffers. For thrombin-stimulation studies, blood was col- 
lected into acid-citrate-dextrose anticoagulant (8.5  x  10  -2 M trisodium ci- 
trate, 6.5  ×  10  -2 M citric acid,  1.11 ×  10  -~ M dextrose, pH 4.5) in the ra- 
tio of one part of anticoagulant to six parts of blood. For ADP-stimulation 
studies,  1.05  ×  10  -~  M  buffered  citrate  solution  was  used  as  the  an- 
ticoagulant in a ratio of one part of citrate to nine parts of blood. Briefly, 
the platelets were isolated by a two-step differential centrifugation proce- 
dure.  Prostaglandin El  (Sigma Chemical Co.,  St.  Louis,  MO)  was in- 
cluded in the anticoagulant and wash buffers, at a concentration of 5 Izg/ml, 
to inhibit platelet activation. The cells were washed twice in buffer contain- 
ing  1.4  x  10  -1  M  NaCI,  2.0  x  10  -2 M  Hepes,  6.0  ×  10  -3 M  glucose, 
pH 6.6; resuspended in a modified Tyrode's buffer containing 0.35% bovine 
serum albumin, without added Ca2+; and allowed to equilibrate for 1 h at 
37°C. 
Thrombin Stimulation 
After adjusting the calcium concentration to 0.001  M, we stimulated 2  x 
109 platelets with 2 U of purified human ct-thrombin (3,150  U/mg) (gift of 
Dr. John Fenton II, New York State Department of Health, Albany, NY). 
After 5 s, 30 s, 1 min, or 5 rain of thrombin stimulation, 20 vol of fixative 
(either 2%  paraformaldehyde  +  0.05%  glutaraldehyde,  pH 7.2,  or 4% 
paraformaldehyde-lysine-periodate [30]) were added to the platelets. Cells 
were fixed for 1 h at 37°C in the first fixative or for 4 h at 40C in the second 
fixative. They were then washed in 0.1 M PBS with 0.05 M  NI-I4CI, pH 7.2, 
to quench excess aldehyde groups. Fixed cells were next settled onto cover- 
slips coated with poly-L-lysine (1  mg/ml distilled H20;  Miles Scientific, 
Naperville,  IL).  For control studies, a  sample of unstimulated cells was 
similarly processed in the absence of thrombin. Other samples of unstimu- 
lated and thrombin-activated platelets were reserved for use in immuno- 
chemical studies in suspension. 
ADP Stimulation 
Platelets isolated as described above were washed, resuspended in Tyrode's 
buffer containing 2.0% bovine serum albumin, allowed to equilibrate for 1 h 
at 22°C, and processed in one of the following ways, after adjustment of 
the final Ca  :+  concentration to  0.001  M:  (a)  ligand-binding-competent 
cells, receptors unoccupied; no exogenous fibrinngen was added;  (b) li- 
gand-binding-compelent cells, receptors occupied; 0.25 mg/ml fibrinogen 
(Kabi Diagnostica, Stockholm, Sweden) was added, and the cells were not 
stirred after ADP was added; (c) aggregating cells; 0.25 mg/mi fibrinogen 
was added, and the cells were stirred continuously after ADP was added. 
Before ADP stimulation, pla.tel[ts  in all three groups were diluted in Ty- 
rode's buffer to  a  concentration of 250,000 cells/ram  3 and  incubated at 
37"C for 5 min. Each sample was then stimulated with 20 IzM ADP (Sigma 
Chemical Co.) diluted in Owren's veronal buffer (2.84  x  10  -2 M  sodium 
barbital  in  1.25  ×  10  -1  M  sodium chloride;  American Dade,  Aguado, 
Puerto Rico) for 5 rain at 37°C. The platelets were then fixed as described 
above and processed in the same way as thrombin-stimulated platelets. 
Aggregometry 
Routine aggregometry was performed on washed platelets from each of the 
three ADP-stimulation groups at a  celt  concentration of 250,000 plate- 
lets/mm  3 and a final ADP concentration of 20 p.M. Aggregation was moni- 
tored in a Bio/Data Platelet Aggregation Profiler, model PAP-2A (Bio/Data 
Corp., Willow Grove, PA). 
Synthetic Peptides 
Arg-Gly-Asp-Ser (RGDS)  and Arg-Gly-Glu-Ser (RGES)  were purchased 
from Peninsula Laboratories, Belmont, CA. The decapeptide ),402-411  was 
synthesized by  the Biomolecular  Resource  Center  at  the  University of 
California, San Francisco. The compounds were tested for cell lysis using 
a lactate dehydrogenase assay (Sigma Chemical Co.) and found to be non- 
lytic at concentrations of 500 I.tM for the tetrapeptides and 1 mM for the 
decapeptide. The peptides were used at concentrations that inhibited fibrin- 
ogen-mediated aggregation, as assessed by aggregometry. These concentra- 
tions were 200 p_M for RGDS and RGES and 835/.tM for the decapeptide, 
although RGDS and the decapeptide could effectively inhibit aggregation at 
concentrations of 50 and 200 ~M, respectively, if the bovine serum albumin 
percentage was decreased from 2.0 % to 0.35 %.  However, for comparison 
with the previous ADP-stimulation studies, the albumin concentration was 
kept at 2.0%. The peptides were supplied to platelets in place of fibrinogen 
before ADP stimulation, as described above. 
Immunochemical Procedures 
Cells in Suspension.  Fixed piatelets were immunolabeled according to the 
procedures of Stenberg et al. (52), with rabbit anti-GPIIIa (1:100 dilution) 
(6) as the primary antibody and protein A-gold (5 nm diam) (Janssen Phar- 
maceuticals, Beerse, Belguim) as the electron-dense marker. The platelets 
were then postfixed in glutaraldehyde and osmium tetroxide and processed 
for thin-sectioning electron microscopy as described previously (52). 
Platelets Settled on Coverslips. Fixed unstimulated, thrombin-stimulat- 
ed,  or  ADP-stimulated platelets  that had  attached to  the poly-L-lysine- 
coaled coverslips were rinsed with PBS containing 0.2% gelatin. The cover- 
slips were then incubated overnight at 4°C with one of four primary antibodies 
at  the dilutions or  protein concentrations given:  polyclonal anti-GPIIIa 
(1:100) (6), monoclonal Tab (0.039 mg/mi) (28), monoclonal T10 (0.02 mg/ 
mi) (29),  polyclonal antifibrinogen (1:5,000)  (Cappel Laboratories,  West 
Chester, PA). Preimmune rabbit serum was used as a control. The cover- 
slips were then rinsed in PBS +  gelatin, and incubated for 1 h at 22°C with 
protein A-gold, 10 nm diam, at a dilution of 1:50 (Janssen Pharmaceuticals). 
The cells were fixed for 15 rain at 25°C in 1.5%  glutaraldehyde in 0.1  M 
cacodylate buffer (pH 7.2), rinsed in the same buffer, postfixed for 15 min 
at 4°C in veronal acetate-buffered 1%  osmium tetroxide,  and dehydrated 
through graded ethanols at 4°C. 
Preparation of Surface Replicas 
Our modifications of a previously described procedure (47) for preparing 
surface replicas are given in detail elsewhere (22). Briefly, dehydrated poly- 
L-lysine-coated coverslips with  adherent,  immunolabeled platelets were 
placed in a critical-point-drying apparatus (Polysciences, Inc., Warrington, 
PA) and processed using bone-dry carbon dioxide as a transition fluid. After 
critical-point drying, the coverslips were mounted on the stage of a Balzers 
360M freeze-fracture apparatus (Balzers Union, Hudson, NH) and the bell 
jar  was  evacuated.  Rotary-shadowed  surface replicas  were  made  using 
platinum-carbon  (<40°),  followed  by  carbon  (<90°),  electrodes.  The 
replicas were floated onto 5.25% NaCIO (Purex Corp., Lakewood, CA) for 
a  brief digestion period.  They were then washed in distilled water and 
picked up on uncoated grids. Specimens were examined and photographed 
with a JEOL 100CX electron microscope at an accelerating voltage of 80 kV. 
Quantitation of Receptors 
Gold particles, existing as either singletons or members of a cluster of two 
or more particles, were counted over a measured area of the plasma mem- 
branes of platelets from activated and unstimulated samples. The number 
of receptors per platelet was determined by multiplying the particle count 
by a factor derived from the work of Mosher et at. (32), who have calculated 
the surface areas of unstimulated and stimulated platelets to be 22  x  10  -~2 
m 2 and >32  ×  10  -12 m 2, respectively. 
Results 
To assess the surface distribution of the platelet fibrinogen 
receptor and its ligand on intact platelets, we initially exam- 
ined thin sections of immunocytochemically labeled unstimu- 
lated and thrombin-activated cells. In unstimulated platelets, 
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membrane, in no apparent pattern, at a density of 6.4 d- 3.8 
gold particles/lam of membrane (Fig. 1). Thrombin stimula- 
tion resulted in prominent change in shape and aggregation 
of the platelets; the density of gold particles increased to 9.0 
+  1.0/~tm of plasma membrane (Fig. 2), but the clustering 
observed  by  other  investigators  was  not  seen.  This  dis- 
crepancy was probably due to our use of protein A-gold as 
the immunoprobe; previous investigators used IgG-gold, a 
reagent that is often inherently clumped (i.e., more than one 
gold particle per IgG molecule). To determine whether plate- 
let activation might cause changes in the surface distribution 
of GPIIb-IIIa not appreciable in conventional thin sections, 
we studied surface replicas of immunolabeled unstimulated 
and thrombin-activated platelets. 
Surface Replicas 
Fibrinogen Receptor Glycoproteins. On the surfaces of un- 
stimulated platelets incubated with anti-GPIIIa, gold parti- 
cles  were uniformly distributed  in  an unclustered pattern 
(Fig. 3). 95 % of the gold particles were monodispersed, and 
the remainder were either doublets (4%) or triplets (1%). 
Thrombin stimulation caused several significant changes 
in the platelets.  Prominent filopodial projections appeared 
and the platelets aggregated (Fig.  4,  inset).  Although the 
amount of immunolabeling  for GPIIIa on the  surfaces of 
Figures 1 and2.  (Fig. 1) Thin section of  a fixed, unstimulated platelet incubated with anti-GPIIIa antiserum. The immunogold label (arrow- 
heads) is distributed over the entire plasma membrane of the cell. However, as has been previously shown (56), fixation renders the GPIIb- 
llIa located on surface-connected canalicular membranes inaccessible to the immunoprobes. (a) a-Grannie; (M) mitochondri0n; (G) glyco- 
gen.  Bar, 0.1  lan.  (Fig. 2) Thin section of aggregated platetets activated with thrombin for 1 min and immunolabeled for GPlna as 
in Fig. 1. The gold probe (arrowheads) is distributed as in unstimulated platelets, with no apparent clustering. Because of the close apposi- 
tion of neighboring platelets, the immunoprobes could not reach membranes within the aggregates. Bar, 0.1  ~un. 
Isenberg ct al. Fibrinogen Receptor Clustering  in Activated  Platelets  1657 Figures 3-5.  (Fig. 3) Surface replica of an unstimulated platelet immunolabeled with anti-GPIIIa. The antigen is uniformly distributed 
over the entire surface of the cell. Bar, 0.1 lun. (Inset)  The discoid nature of unstimulated platelets. Bar,  1 ~m3. (Fig. 4) Surface replica 
of a thrombin-stimulated platelet immunolabeled with anti-GPIIIa antibody. At all periods of stimulation examined, the extent of labeling 
in individual cells varied. Most platelets showed approximately the same number of gold particles seen in unstimulated cells, in addition 
to clustering of the antigen (arrowheads).  The blackened areas at the corners of the figure represent long filopodial projections that have 
fallen back onto the surface of the cell. Since such projections were often not extracted in the bleach digestion step, assessment of receptor 
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Figure 6. Patterns of gold particles on surface replicas of unstimu- 
lated and thrombin-activated platelets. Gold particles were counted 
on 60 platelets in each group. 
these activated platelets varied greatly, most cells showed ap- 
proximately the same number of gold particles per unit area 
as unstimulated cells, or about 10,000 gold particles per plate- 
let (Fig. 4). However, on all cells ~65 % of the gold particles 
were now clustered. Binding studies using radiolabeled anti- 
bodies to the receptor have shown that each platelet bears 
'~40,000-50,000 GPIIb-IIIa complexes (29,  38). The dimi- 
nution in number of sites with the surface-replica procedure 
may be due to steric hindrance of the immunoprobes used, 
fixation sensitivity of the antigen, or other factors. Indeed, 
Griffiths and Hoppeler (18) have reported only a  14 % label- 
ing  efficiency of plasma-membrane  proteins  for immuno- 
electron-microscopic methods in comparison to biochemical 
assays.  The clustering of the gold particles was more clearly 
apparent at higher magnifcation (Fig. 5). The patterns ofim- 
munolabeling with two monoclonal antibodies, Tab,  which 
recognizes GPIIb, and T10, which recognizes an epitope on 
the GPIIb-IIIa complex in the presence of Ca  2+, were indis- 
tinguishable from the pattern with anti-GPIIIa. No immuno- 
gold label was observed when preimmune rabbit serum was 
used in place of antibodies to the receptor glycoproteins. The 
differences in GPIIb-IIIa-labeling patterns on unstimulated 
and thrombin-activated platelets are summarized in Fig. 6. 
The Physiological  Ligand,  Fibrinogen.  The virtual ab- 
sence of label on the surfaces of unstimulated platelets im- 
munolabeled with antifibrinogen antiserum (Fig. 7) showed 
that there was no immunoreactive fibrinogen bound to these 
cells. Thrombin stimulation caused the secretion of a-granule 
contents and the subsequent binding of the endogenous fi- 
brinogen  to  its  cell-surface receptors  (Fig.  8).  At  higher 
magnification, the immunoprobe for the ligand showed clus- 
tering similar to that seen with antibodies to the glycopro- 
teins of the receptor (Fig.  5). 
ADP Stimulation 
From  the  experiments with  thrombin,  we  concluded that 
both fibrinogen and its receptor clustered in the plane of the 
plasma membrane after physiologic activation of platelets. 
Figures 7 and 8.  (Fig. 7) Surface replica of an unstimulated platelet immunolabeled with antifibrinogen antibody. There is virtually no 
immunoreactive ligand bound to the surface of  the cell. Bar, 0.1 lam. (Fig. 8) Surface replica ofa thrombin-activated platelet immunolabeled 
with antifibrinogen antibody. The gold probe is present in high concentrations and is clustered (arrowheads). Bar, 0.1 lma. 
and ligand distribution at these sites is difficult. Bar, 0.1 lam. (Inset) Low-power view of a surface-replicated microaggregate of thrombin- 
activated platelets. The shape change seen on thin-section profiles in Fig. 2 is also apparent here. Bar, 1 pan. (Fig. 5) Magnified view of 
surface replica of a thrombin-activated platelet immunolabeled with anti-GPIIIa.  Clustering of the immunoprobe is indicated by arrow- 
heads. Bar, 0.1  lain. 
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Figure 9. Aggregometry tracings of the three groups of platelets in 
the ADP-stimulation studies. (A) Binding-competent, receptors un- 
occupied; (B) binding-competent, receptors occupied, nonaggre- 
gated; and (C) binding-competent, receptors occupied, aggregated. 
The conditions of preparing the platelets are indicated in the lower 
left corner of each panel. 
However, because thrombin also causes the release of a-gran- 
ule contents (including fibrinogen), we could not determine 
whether receptors  that are competent for ligand binding clus- 
ter before or after they bind fibrinogen. We therefore per- 
formed experiments using ADP. Although at low doses this 
agonist does not induce a-granule secretion, it does cause 
platelets to change shape, bind exogenous fibrinogen, and, 
if stirred,  aggregate (27)  (Fig.  9).  The-bind!ng-competent 
receptor, therefore, remains unoccupied unless fibrinogen is 
added. By comparing the topographic distribution of GPIIb- 
IIIa on ADP-activated platelets prepared with and without 
added fibrinogen, we could ascertain whether receptor clus- 
tering occurs prior to, or as a consequence of, ligand binding. 
Binding-competent but Unoccupied by Ligand. Platelets 
that were stimulated with ADP in the absence of fibrinogen 
underwent shape change but did not aggregate as assessed 
by aggregometry (Fig.  9  a) and morphologic study.  They 
showed monodisperse surface distribution of fibrinogen re- 
ceptors (Fig. 10) and lacked surface immunoreactive fibrino- 
gen (Fig.  11). 
Binding-competent  and  Occupied  by  Ligand.  When 
platelets were stimulated with ADP in the presence of added 
fibrinogen, but not stirred, they changed shape, but did not 
aggregate (Fig. 9 b). They showed clustering of fibrinogen 
receptors, with 55 % of the gold particles per cell in clusters 
(not illustrated).  Studies with antifibrinogen antibody showed 
that the ligand was also clustered in such cells, although there 
was less immunolabel for fibrinogen than in thrombin-stimu- 
lated cells. 
When platelets were processed in the same way as the un- 
stirred cells, but were stirred after the addition of ADP, they 
underwent aggregation as assessed by aggregometry (Fig. 9 
c). They showed the same surface distribution of fibrinogen 
receptors and ligand as the unstirred cells. Thus, ligand bind- 
ing, but not aggregation, is required for receptor clustering. 
Binding-competent  and Occupied by GPIIb-llla-bind- 
ing Domains of Fibrinogen. To determine whether GPIIb- 
IIIa clustering is due to the polyvalent nature of the fibrino- 
gen molecule, or merely a function of receptor occupancy, 
we substituted RGES, RGDS, or 7402-411  for fibrinogen in 
ADP-stimulation  studies.  RGDS  and 7402-411  have been 
shown to be the GPIIb-IIIa-binding domains on the ct- and 
7-chains, respectively, of  the fibrinogen molecule (25, 35, 41, 
45).  Gartner et al.  (14, 15) have demonstrated that RGES 
does not compete with fibrinogen binding to platelets as does 
RGDS, even though it differs chemically from RGDS by only 
one methyl group. Therefore, RGES was used as a control 
peptide. Incubation of ADP-stimulated platelets with RGDS 
(Fig.  12)  or  the  decapeptide  (not illustrated)  also  caused 
clustering of GPIIb-HIa. The GPlIb-IIIa molecules remained 
monodispersed when RGES was substituted for fibrinogen in 
ADP-activated platelets (not illustrated). 
Discussion 
In this study, we have used surface replication of immunola- 
beled intact platelets to examine the topographic distribution 
of fibrinogen and its  receptor on unstimulated,  thrombin- 
activated, and ADP-activated cells. In unstimulated platelets, 
GPIIb-IIIa was uniformly monodispersed over the surface of 
the cell. GPIIb-IIIa does not bind fibrinogen on unstimulated 
platelets,  and  accordingly,  there  was  no  immunoreactive 
fibrinogen on the plasma membranes of these cells.  After 
thrombin stimulation, ~,~65  % of the immunolabeled GPIIb- 
IIIa was  clustered in the  plane of the plasma membrane. 
Thrombin stimulation also causes platelet a-granules to se- 
crete fibrinogen, which subsequently binds to GPIIb-IIIa on 
the cell surface. This bound fibrinogen was  similarly clus- 
tered. To ascertain whether GPIIb-IIIa clustered before, or 
as a consequence of, ligand binding in activated platelets, we 
also analyzed ADP-activated platelets. ADP induces the ex- 
pression of fibrinogen receptors on the platelet plasma mem- 
brane,  but it does so without causing  a-granule  secretion 
(27). On the surfaces of ADP-stimulated cells whose recep- 
tors were ligand-binding-competent, but unoccupied, GPI/b- 
Ilia  remained monodispersed.  However, when fibrinogen 
was added, either in its native form or as the RGDS or 7402- 
411  active GPIIb-IIIa-binding peptides,  the GPIIb-IIIa on 
ADP-stimulated cells was clustered. 
We conclude that GPIIb-IIIa clustering occurs on activated 
platelets as a consequence of receptor occupancy. That not 
all of the receptors clustered after thrombin stimulation may 
be due to the experimental conditions. The thrombin studies 
were performed on washed platelets, so all of the fibrinogen 
available  for binding had been  secreted from a-granules. 
Plow et al. (40) have calculated that there is sufficient plate- 
let-derived fibrinogen to occupy '~30%  of the GPIIb-IIIa 
molecules. Therefore, ligand concentration may determine 
the  degree of receptor clustering.  Similar  ligand-induced 
receptor clustering  has  been described for the  epidermal 
growth factor receptor on intact (19) and plasma membrane 
vesicles (58) of A431 cells. These findings suggest that re- 
ceptor occupancy alone may be sufficient to promote homo- 
typic  receptor  interactions  in  some  cell  types.  However, 
there is no evidence that the GPIIb-IIIa/fibrinogen complex 
The Journal  of Cell Biology,  Volume  104, 1987  1660 Figures 10-12.  (Fig.  10) Surface replica of a washed platelet stimulated with ADE Because fibrinogen was not added, the receptors were 
unoccupied, even though they were binding-competent. The cell was fixed, immunolabeled  with the monoclonal antibody Tab, and surface- 
replicated. The gold probe, bound to GPIIb, is monodispersed over the platelet surface. Bar, 0:1 ~am. (Fig. 11) Surface replica of a platelet 
stimulated with ADP as described in Fig.  10 and exposed to antifibrinogen. No immunoreactive fibrinogen is present. Bar, 0.1  Ima. (Fig. 
12) Replica of the immunolabeled  surface of a platelet stimulated with ADP in the presence of RGDS, and probed with Tab, the monoclonal 
antibody to GPIIb. The gold probe is clustered at several sites (arrowheads).  Bar, 0.1  lain. 
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the case with most other receptor-ligand complexes. 
The significance of GPl/b-IIIa clustering in platelets is un- 
known; however, clustering is known to be an antecedent to 
biological responses  for a  variety of receptors,  including 
those for epidermal growth factor (49, 50, 54), insulin (24), 
and IgE (31). In the study on IgE receptors, the in~/estigators 
concluded that the association of the IgE receptor with Ca  2+ 
channels, a second messenger system common to many cell 
types, including the platelet (4, 46), may depend upon clus- 
tering. It remains to be determined whether GPIIb-IIIa clus- 
tering after fibrinogen binding serves the purpose of (a) sig- 
nal transduction, (b) ion channel modulation, as proposed by 
several investigators (2, 5, 44), or (c) establishing microdo- 
mains within the plasma membrane for cytoskeletal anchor- 
ing (34,  37). However,  not all glycoproteins that are ex- 
pressed on the surface of the activated platelet cluster.  We 
have recently reported on the surface distribution of GMP- 
140, an  a-granule integral membrane glycoprotein in the 
resting platelet that is expressed on the plasma membrane af- 
ter physiologic (22,  53) or pathologic (17) activation. Even 
at the latest time point analyzed, 5 min after thrombin activa- 
tion,  ~90%  of the immunogold probe  for GMP-140  was 
monodispersed. This glycoprotein, then, serves as an impor- 
tant control, indicating that clustering of gold-labeled glyco- 
proteins is not merely an epiphenomenon associated with 
physiologic  changes  in  platelet  shape  and/or  membrane 
fluidity. 
In addition to its ability to bind the RGDS domain on the 
a-chain of fibrinogen, the GPUb-IIIa molecular complex has 
broader interest as a member of a family of Arg-Gly-Asp- 
specific cell adhesive protein receptors (45, 48). Fibrinogen, 
fibronectin, vitronectin, and von Willebrand factor all con- 
tain at least one RGDX sequence. Gardner and Hynes (13) 
have shown that the cell-attachment domain of fibronectin 
that binds to fibroblasts also binds to an inducible receptor 
on activated platelets, GPIIIa being the glycoprotein iden- 
tiffed. With the finding of GPIIb-IIIa-related proteins on en- 
dothelial cells (10, 26), smooth muscle cells, fibroblasts (8, 
42), and leukocytes (7, 42), a clearer understanding of cell- 
adhesive events at the molecular level  in physiologic and 
pathologic thrombosis becomes a realistic goal. 
We have determined that receptor occupancy alone is suffi- 
cient to induce clustering, and that the ligand need not be 
polyvalent to cross-link GPIIb-IIIa in the plane of the mem- 
brane. Other investigators (33, 57) have used concanavalin 
A, a tetravalent ligand that activates platelets and induces in- 
teractions between GPIIb-IIIa and the platelet cytoskeleton. 
Painter et al. (33) concluded that this association between the 
fibrinogen receptor glycoproteins and the actin cytoskeleton 
required clustering of GPIIb-IIIa molecules,  and that the 
polyvalency of concanavalin A  mediated such clustering. 
However,  Phillips  and  co-workers  (37) found  substantial 
amounts of GPIIb-IIIa only in the Triton-insoluble cytoskele- 
tons of "aggregated" thrombin-activated platelets, indicating 
that activation of the fibrinogen binding function of GPIIb- 
IIIa (with subsequent binding of the polyvalent fibrinogen 
molecule), is temporally distinct from cytoskeleton-medi- 
ated aggregation of platelets.  Because our  ADP-activated 
platelets showed clustering of receptors even in the absence 
of aggregation, we conclude that the cytoskeleton does not 
direct  receptor clustering, but rather,  that ligand-induced 
GPIlb-IUa clustering, mediated by receptor occupancy alone, 
promotes subsequent association with the actin cytoskeleton. 
Therefore, we propose the following model for ligand-recep- 
tor-cytoskeleton interaction at the platelet plasma membrane 
after physiologic activation: (a) ADP or thrombin induces a 
change in the GPIIb-IIIa complex that makes the receptor fi- 
brinogen-binding-competent; (b) when available, as in throm- 
bin-stimulated platelets,  or when exogenously supplied to 
ADP-activated platelets, fibrinogen binds to GPIIb-IIIa; (c) 
the occupied receptors cluster and establish a microenviron- 
ment in the plasma membrane that facilitates interaction be- 
tween  the  clustered  glycoproteins  and  the  platelet  cyto- 
skeleton. 
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